Discover 134 paid clinical trials in Chattanooga, Tennessee. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 134
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
for
COPD (Chronic Obstructive Pulmonary Disease)
Location: Chattanooga TN, Tullahoma TN, Tucker GA, Franklin TN,
Sponsor: AstraZeneca
Sex: All
Age: 40 - 70+
Code: NCT06283966
Phase3, Recruiting
Study to Assess Real-world Effectiveness of Belimumab for Treatment of Adults With LN
for
Lupus Nephritis
Location: Hixson TN, Charlotte NC, Columbus OH, Baltimore MD
Sponsor: GlaxoSmithKline
Sex: All
Age: 18+
Code: NCT06527872
Recruiting
Intravitreal Faricimab Injections or Fluocinolone Acetonide (0.19 mg) Intravitreal Implants vs Observation for Prevention of VA Loss Due to Radiation Retinopathy
for
Radiation Retinopathy, Visual Impairment
Location: Hixson TN, Atlanta GA, Nashville TN, Greenville SC,
Sponsor: Jaeb Center for Health Research
Sex: All
Age: 18+
Code: NCT05844982
Phase3, Recruiting
Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial
Get alerts for new trials in your area by subscribing now
A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
for
Graves' Disease
Location: Chattanooga TN, Atlanta GA, Nashville TN,
Sponsor: Immunovant Sciences GmbH
Sex: All
Age: 18 - 70+
Code: NCT06727604
Phase2, Recruiting
A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
for
Non-alcoholic Fatty Liver Disease
Location: Chattanooga TN, Springboro OH, St Louis MO,
Sponsor: GlaxoSmithKline
Sex: All
Age: 18 - 70+
Code: NCT07221188
Phase3, Recruiting
A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
Comparison of Epi-ON Corneal Collagen Crosslinking Performed Using an 18-Minute UVA Exposure vs. a 24-Minute UVA Exposure on Eyes With Ectatic Corneal Diseases
for
Keratoconus, Ectasia of Cornea,
Location: Chattanooga TN, Canton GA, Marietta GA, Knoxville TN,
Sponsor: Woolfson Eye Institute
Sex: All
Age: 8+
Code: NCT07124910
Phase3, Recruiting
Compassionate Use Study of Epi-ON Corneal Collagen Crosslinking Performed Using UVA Exposure on Eyes With Ectatic Corneal Diseases for Subjects With Down Syndrome
for
Down Syndrome (DS), Keratoconus, Pellucid Marginal Degeneration,
Location: Chattanooga TN, Canton GA, Marietta GA, Knoxville TN,
Sponsor: Woolfson Eye Institute
Sex: All
Age: 8+
Code: NCT07135167
Phase3, Recruiting
Safety and Effectiveness of the PXL Platinum 330 System With Riboflavin Solution for Previously Untreated Corneal Ulcers
for
Keratitis, Corneal Ulcer
Location: Chattanooga TN, Columbia SC, Indianapolis IN, Tampa FL,
Sponsor: Peschke GmbH
Sex: All
Age: 18+
Code: NCT05255107
Phase2, Phase3, Recruiting
Post-market Surveillance Study of the BD® WavelinQ™ EndoAVF System